|
Market Closed -
Swiss Exchange
19:30:30 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 103.60 CHF | +0.19% |
|
+0.83% | +14.02% |
| 10-23 | Swiss Market Index Ends Week on Negative Note; Sika, Novartis Shares Down | MT |
| 10-23 | SGS SA, Q3 2026 Sales/ Trading Statement Call, Oct 23, 2026 |
Company Valuation: SGS SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,837 | 16,107 | 13,370 | 16,937 | 17,587 | 20,471 | - | - |
| Change | - | -29.47% | -16.99% | 26.68% | 3.84% | 16.4% | - | - |
| Enterprise Value (EV) 1 | 24,528 | 18,930 | 16,209 | 19,607 | 20,153 | 23,577 | 23,104 | 22,927 |
| Change | - | -22.82% | -14.38% | 20.97% | 2.78% | 16.99% | -2.01% | -0.77% |
| P/E | 37.3x | 27.3x | 24.3x | 29.4x | 26.3x | 27.5x | 24.6x | 22.9x |
| PBR | 20.4x | 23.5x | 29.1x | 21.4x | 19.5x | 14.6x | 11.1x | 9.12x |
| PEG | - | -7.16x | -4.88x | 8.79x | 2.2x | 3.11x | 2x | 3.11x |
| Capitalization / Revenue | 3.57x | 2.43x | 2.02x | 2.49x | 2.53x | 2.67x | 2.48x | 2.35x |
| EV / Revenue | 3.83x | 2.85x | 2.45x | 2.89x | 2.9x | 3.07x | 2.8x | 2.64x |
| EV / EBITDA | 16.2x | 12.7x | 11.4x | 13.3x | 13.1x | 13.9x | 12.6x | 11.8x |
| EV / EBIT | 23.2x | 18.5x | 16.7x | 18.9x | 18.2x | 19.1x | 17x | 15.7x |
| EV / FCF | 38.6x | 37.3x | 25.5x | 26.2x | 24x | 26.6x | 23.5x | 21.5x |
| FCF Yield | 2.59% | 2.68% | 3.92% | 3.81% | 4.17% | 3.76% | 4.25% | 4.64% |
| Dividend per Share 2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.202 | 3.31 | 3.443 |
| Rate of return | 2.63% | 3.72% | 4.41% | 3.52% | 3.52% | 3.09% | 3.19% | 3.32% |
| EPS 2 | 3.272 | 3.147 | 2.99 | 3.09 | 3.46 | 3.766 | 4.219 | 4.53 |
| Distribution rate | 97.8% | 102% | 107% | 104% | 92.5% | 85% | 78.5% | 76% |
| Net sales 1 | 6,405 | 6,642 | 6,622 | 6,794 | 6,945 | 7,673 | 8,239 | 8,698 |
| EBITDA 1 | 1,515 | 1,489 | 1,424 | 1,478 | 1,539 | 1,702 | 1,839 | 1,951 |
| EBIT 1 | 1,055 | 1,023 | 971 | 1,040 | 1,108 | 1,236 | 1,359 | 1,459 |
| Net income 1 | 613 | 588 | 553 | 581 | 668 | 746.3 | 845.3 | 916.8 |
| Net Debt 1 | 1,691 | 2,823 | 2,839 | 2,670 | 2,566 | 3,106 | 2,633 | 2,456 |
| Reference price 2 | 121.88 | 86.00 | 72.54 | 90.88 | 90.86 | 103.60 | 103.60 | 103.60 |
| Nbr of stocks (in thousands) | 187,376 | 187,292 | 184,309 | 186,371 | 193,566 | 197,600 | - | - |
| Announcement Date | 1/27/22 A | 1/26/23 A | 1/26/24 A | 2/11/25 A | 2/11/26 A | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.51x | 3.07x | 13.85x | 3.09% | 24.85B | |
| 33.01x | 17.01x | 24.19x | 0.65% | 769B | |
| 39.88x | 7.25x | 25.73x | 0.9% | 87.29B | |
| 24.18x | 4.82x | 10.5x | 0.68% | 72.45B | |
| 11.24x | 1.46x | 7.24x | 0.99% | 47.36B | |
| 44.13x | 1.69x | 9.5x | -.--% | 46.08B | |
| -72.94x | 16.71x | 40.54x | -.--% | 42.25B | |
| 21.64x | 3.6x | 8.54x | 1.47% | 34.27B | |
| 10.51x | 2.68x | 6.46x | -.--% | 26.6B | |
| 20.1x | 6.14x | 11.77x | -.--% | 26.33B | |
| Average | 15.93x | 6.44x | 15.83x | 0.78% | 117.65B | |
| Weighted average by Cap. | 27.49x | 13.05x | 21.44x | 0.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SGSN Stock
- Valuation SGS SA
Select your edition
All financial news and data tailored to specific country editions
